Follow the 우진비앤지 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 우진비앤지 has recorded 45 insider filings. Market capitalisation: €18.6bn. The latest transaction was filed on 15 July 2026 (Purchase). Among the most active insiders: 강재구. The full history is free.
41
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
4 ops.
Sell Volume
Fundamental score
Ranked 21,046 of 28,857 companies
36.3
score / 100
Value
47
Quality
25
FCF yld5.5%
Earn yld-9.3%
EV/EBITDA10.1x
ROE·
Gross mgn30%
Net mgn-3.2%
Debt/EBITDA6.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
우진비앤지 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of pharmaceutical products.